nach oben

Medizinische Klinik - Intensivmedizin und Notfallmedizin

Erschienen in:

29.05.2017 | ECMO | Leitthema

Extrakorporale Verfahren zur Lungenunterstützung

verfasst von: S. Braune, A. Sieweke, D. Jarczak, Prof. Dr. S. Kluge

Erschienen in: Medizinische Klinik - Intensivmedizin und Notfallmedizin | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Zusammenfassung

Verfahren zur extrakorporalen Lungenunterstützung haben in den letzten Jahren eine rapide technologische Weiterentwicklung mit Verbesserung von Effektivität und Sicherheit erfahren. Trotz der derzeit noch sehr begrenzten wissenschaftlichen Evidenz kommen diese Systeme in der Intensivmedizin zunehmend zur Therapie unterschiedlicher Arten akuter respiratorischer Insuffizienzen zum Einsatz. Die Systeme lassen sich in Verfahren zur extrakorporalen Kohlendioxid (CO₂-)Eliminierung (ECCO₂R) bei ventilatorischer Insuffizienz und Verfahren zur extrakorporalen Membranoxygenierung (ECMO) bei schwerer hypoxämischer Insuffizienz unterteilen. Trotz der technologischen Fortentwicklung bleiben extrakorporale Lungenunterstützungsverfahren invasive und potenziell komplikationsträchtige Therapieformen mit Blutungen und Gefäßverletzungen als die beiden Hauptkomplikationen. Daher sollten Indikation und Kontraindikationen stets kritisch abgewogen werden und ihr Einsatz nur in Zentren mit entsprechender Erfahrung und Expertise erfolgen.

Abrams DC, Brenner K, Burkart KM et al (2013) Pilot study of extracorporeal carbon dioxide removal to facilitate extubation and ambulation in exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc 10(4):307–314CrossRefPubMed

Abrams D, Javidfar J, Farrand E et al (2014) Early mobilization of patients receiving extracorporeal membrane oxygenation: a retrospective cohort study. Crit Care 18:R38CrossRefPubMedPubMedCentral

Abrams DC, Prager K, Blinderman CD (2014) Ethical dilemmas encountered with the use of extracorporeal membrane oxygenation in adults. Chest 145:876–882CrossRefPubMed

Allardet-Servent J, Castanier M, Signouret T et al (2015) Safety and efficacy of combined extracorporeal CO₂ removal and renal replacement therapy in patients with acute respiratory distress syndrome and acute kidney injury: the pulmonary and renal support in acute respiratory distress syndrome study. Crit Care Med 43:2570–2581CrossRefPubMedPubMedCentral

Banfi C, Pozzi M, Siegenthaler N et al (2016) Veno-venous extracorporeal membrane oxygenation: cannulation techniques. J Thorac Dis 8(12):3762–3773CrossRefPubMedPubMedCentral

Barbaro RP, Odetola FO, Kidwell KM et al (2015) Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry. Am J Respir Crit Care Med 191:894–901CrossRefPubMedPubMedCentral

Bein T, Weber-Carstens S, Goldmann A (2013) Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO₂ removal versus „conventional“ protective ventilation (6 ml/kg) in severe ARDS. The prospective randomized Xtravent-study. Intensive Care Med 39:847–856CrossRefPubMedPubMedCentral

Biscotti M, Gannon WD, Agerstrand C (2017) Awake extracorporeal membrane oxygenation as bridge to lung transplantation: a 9-year experience. Ann Thorac Surg. doi:10.1016/j.athoracsur.2016.11.056 PubMed

Braune S, Kienast S, Hadem J et al (2013) Safety of percutaneous dilatational tracheostomy in patients onextracorporeal lung support. Intensive Care Med. doi:10.1007/s00134-013-3023-8 PubMed

10.

Braune S, Kluge S (2013) Extracorporeal lung support in patients with chronic obstructive pulmonary disease. Minerva Anestesiol 79:934–943PubMed

11.

Braune S, Sieweke A, Brettner F et al (2016) The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): multicentre case-control study. Intensive Care Med 42:1437–1444CrossRefPubMed

12.

Brenner K, Abrams DC, Agerstrand CL et al (2014) Extracorporeal carbon dioxide removal for refractory status asthmaticus: experience in distinct exacerbation phenotypes. Perfusion 29(1):26–28CrossRefPubMed

13.

Brochard L, Martin GS, Blanch L et al (2012) Clinical review: respiratory monitoring in the ICU – a consensus of 16. Crit Care 16:219CrossRefPubMedPubMedCentral

14.

Burki NK, Mani RK, Herth FJF et al (2013) A novel extracorporeal CO₂ removal system. Results of a pilot study of hypercapnic respiratory failure in patients with COPD. Chest 143(3):678–686CrossRefPubMed

15.

Combes A, Brodie D, Bartlett R (2014) Position paper for the organization of extracorporeal membrane oxygenation programs for akute respiratory failure in adult patients. Am J Respir Crit Care Med 190(5):488–496CrossRefPubMed

16.

Cove ME, MacLaren G, Federspiel WJ et al (2012) Bench to bedside review: extracorporeal carbon dioxide removal, past present and future. Crit Care 16:232CrossRefPubMedPubMedCentral

17.

Davies A, Jones D, Beca J et al (2009) Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome. JAMA 302(17):1888–1895CrossRefPubMed

18.

Del Sorbo L, Boffini M, Rinaldi M (2012) Bridging to lung transplantation by extracorporeal support. Minerva Anestesiol 78(2):243–250PubMed

19.

Del Sorbo L, Fan E, Nava S et al (2016) ECCO₂R in COPD exacerbation only for the right patients and with the right strategy. Intensive Care Med 42:1830–1833CrossRefPubMed

20.

Del Sorbo L, Pisani L, Filippini C (2015) Extracorporeal CO₂ removal in hypercapnic patients at risk of noninvasive ventilation failure: a matched cohort study with historical control. Crit Care Med 43:120–127CrossRefPubMed

21.

Enger TB, Philipp A, Videm V et al (2014) Prediction of mortality in adult patients with severe acute lung failure receiving veno-venous extracorporeal membrane oxygenation: a prospective observational study. Crit Care 18(2):R27CrossRef

22.

Extracorporeal Life Support Organization. https://www.elso.org/. Zugegriffen: 26. April 2017

23.

Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome (EOLIA). https://clinicaltrials.gov/ct2/show/NCT01470703. Zugegriffen: 26. April 2017

24.

Fan E, Gattinoni L, Combes A et al (2016) Venonenous extracorporeal membrane oxygenation for acute respiratory failure. A clinical review from an international group of experts. Intensive Care Med 42:712–724CrossRefPubMed

25.

Fitzgerald M, Millar J, Blackwood B et al (2014) Extracorporeal carbon dioxide removal for patients with acute respiratory failure secondary to the acute respiratory distress syndrome: a systematic review. Crit Care 18(3):222CrossRefPubMedPubMedCentral

26.

Forster C, Schriewer J, John S et al (2013) Low-flow CO₂ removal integrated into a renal replacement circuit can reduce acidosis and decrease vasopressor requirements. Crit Care 17(4):R154CrossRefPubMedPubMedCentral

27.

Fuehner T, Kuehn C, Hadem J et al (2012) Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. Am J Respir Crit Care Med 185(7):763–768CrossRefPubMed

28.

Gattinoni L, Tonetti T, Quintel M (2017) How best to set the ventilator on extracorporeal membrane lung oxygenation. Curr Opin Crit Care 23:66–72CrossRefPubMed

29.

Gattinoni L, Marini JJ, Pesenti A et al (2016) The „baby lung“ became an adult. Intensive Care Med 42(5):663–673CrossRefPubMed

30.

Gottschalk A, Bräuning J, Brause D (2016) Early goal directed physiotherapy in patients undergoing extracorporeal cardiac life support. Int J Sci Eng Res 7(1):1589–1600

31.

Graf T, Thiele H (2017) Kardiale Unterstützungs- und Ersatzsysteme. Med Klin Intensivmed Notfmed. doi:10.1007/s00063-017-0295-8

32.

Gray BW, Haft JW, Hirsch JC et al (2015) Extracorporeal life support: experience with 2000 patients. ASAIO J 61:2–7CrossRefPubMedPubMedCentral

33.

Hoeper MM, Wiesner O, Hadem J (2013) Extracorporeal membrane oxygenation instead of invasive mechanical ventilation in patients with acute respiratory distress syndrome. Intensive Care Med 39(11):2056–2057CrossRefPubMed

34.

Kalbhenn J, Wittau N, Schmutz A et al (2015) Identification of acquired coagulation disorders and effects of target-controlled coagulation factor substitution on the incidence and severity of spontaneous intracranial bleeding during veno-venous ECMO therapy. Perfusion 30(8):675–682CrossRefPubMed

35.

Kalbhenn J, Neuffer N, Zieger B (2017) Is extracorporeal CO₂-removal „safe“ and „less“ invasive? Observation of blood injury and coagulation impairment during ECCO₂R. ASAIO J. doi:10.1097/MAT.0000000000000544 PubMed

36.

Karagiannidis C, Auf’m Kampe K, Sipmann FS (2014) Veno-venous extracorporeal CO₂ removal for the treatment of severe respiratory acidosis. Pathphysiologic and technical considerations. Crit Care 18(3):R124CrossRefPubMedPubMedCentral

37.

Karagiannidis C, Brodie D, Strassmann S et al (2016) Extracorporeal membrane oxygenation: evolving epidemiology and mortality. Intensive Care Med. doi:10.1007/s00134-016-4273-z PubMed

38.

Kluge S, Braune S, Engel M (2012) Avoiding invasive mechanical ventilation by extracorporeal carbon dioxide removal in patients failing noninvasive ventilation. Intensive Care Med 38:1632–1639CrossRefPubMed

39.

Kluge S, Sensen B, Braune S (2017) Extrakorporale Lungenunterstützung bei Patienten mit ARDS. Dtsch Med Wochenschr 142:88–95CrossRefPubMed

40.

Kolobow T, Gattinoni L, Tomlinson TA et al (1977) Control of breathing using an extracorporeal membrane lung. Anesthesiology 46(2):138–141CrossRefPubMed

41.

Kumar A, Zarynchanski R, Pinto R et al (2009) Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA 302(17):1872–1879CrossRefPubMed

42.

Langer T, Santini A, Bottino N (2016) „Awake“ extracorporeal membrane oxygenation (ECMO): pathphysiology, technical considerations, and clinical peoneering. Crit Care 20:150CrossRefPubMedPubMedCentral

43.

Lund LW, Federspiel WJ (2013) Removing extra CO₂ in COPD patients. Curr Respir Care Rep 2:131–138CrossRefPubMedPubMedCentral

44.

Luyt CE, Bréchot N, Demondion P et al (2016) Brain injury during venovenous extracorporeal membrane oxygenation. Intensive Care Med 42(5):897–907CrossRefPubMed

45.

Morelli A, Del Sorbo L, Pesenti A et al (2017) Extracorporeal carbon dioxide removal (ECCO₂R) in patients with acute respiratory failure. Intensive Care Med. doi:10.1007/s00134-016-4673-0

46.

Muellenbach R, Kredel M, Kunze E et al (2012) Prolonged heparin-free extracorporeal membrane oxygenation in multiple injured acute respiratory distress syndrome patients with traumatic brain injury. J Trauma 72(5):1444–1447

47.

Müller T, Bein T, Philipp A et al (2013) Extracorporeal pulmonary support in severe pulmonary failure in adult. Dtsch Arztebl Int 110(10):159–166PubMedPubMedCentral

48.

Napp LC, Kühn C, Bauersachs J (2017) ECMO in cardiac arrest and cardiogenic shock. Herz 42:27–44CrossRefPubMedPubMedCentral

49.

Nierhaus A, Frings DP, Braune S et al (2011) Interventional lung assist enables lung protective mechanical ventilation in acute respiratory distress syndrome. Minerva Anestesiol 77:797–801PubMed

50.

Peek GJ, Mugford M, Tiruvoipati R et al (2009) Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR), a multicentre randomised controlled trial. Lancet 374:1351–1363CrossRefPubMed

51.

Pesenti A, Patroniti N, Fumagalli R (2010) Carbon dioxide dialysis will save the lung. Crit Care Med 38:549–554CrossRef

52.

Petzoldt M, Braune S, Bittmann I et al (2012) Rescue therapy with a pumpless extracorporeal lung assist device in a patient with acute interstitial lung disease and severe refractory hypercapnia. Respir Care 57(2):293–297PubMed

53.

Rozencwajg S, Pilcher D, Combes A et al (2016) Outcomes and survival prediction models for severe adult acute respiratory distress syndrome treated with ECMO. Crit Care 20:392CrossRefPubMedPubMedCentral

54.

Schmidt M, Pilcher D (2014) Mortality prediction models in ARF treated with extracorporeal membrane oxygenation: it must be firstly designed for clinicians and bedside use. Crit Care 18(4):445CrossRefPubMedPubMedCentral

55.

Schmidt M, Tachon G, Devillier C et al (2013) Blood oxygenation and decarboxylation determinants during venovenous ECMO for respiratory failure in adults. Intensive Care Med 39:838–846CrossRefPubMed

56.

Schmidt M, Zogheib E, Rozè H et al (2013) The PRESERVE mortality risc score and analysis of long term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Intensive Care Med 39(10):1704–1713CrossRefPubMed

57.

Serpa Neto A, Schmidt M, Azevedo LC et al (2016) Associations between ventilator settings during extracorporeal membrane oxygenation for refractory hypoxemia and outcome in patients with acute respiratory distress syndrome: a pooled individual patient data analysis: mechanical ventilation during ECMO. Intensive Care Med 42:1672–1684CrossRefPubMed

58.

Sklar MC, Beloncle F, Katsios CM (2015) Extracorporeal carbon dioxide removal in patients with chronic obstructive pulmonary disease: a systematic review. Intensive Care Med. doi:10.1007/s00134-015-3921-z PubMed

59.

Staudinger T (2016) Extracorporeal lung support – news and future developements? Med Klin Intensivmed Notfmed. doi:10.1007/s00063-016-0182-8 PubMed

60.

Strategy of ultraprotective lung ventilation with extracorporeal CO2 removal for new-onset moderate to severe ARDS (SUPERNOVA). https://clinicaltrials.gov/ct2/show/NCT02282657. Zugegriffen: 26. April 2017

61.

Thiagarajan RR, Barbaros RP, Rycus PT (2017) ELSO Registry international report 2016. ASAIO J 63:60–67CrossRefPubMed

62.

Trudzinski FC, Minko P, Rapp D (2016) Runtime and aPTT predict venous thrombosis and thromboembolism in patients on extracorporeal membrane oxygenation: a retrospective analysis. Ann Intensive Care 6:66CrossRefPubMedPubMedCentral

63.

Welterer S, Schmidt K, Deininger M (2016) Komplexe Fokussanierung in der Sepsis. Extrakorporale Membranoxygenierung (ECMO) als Bridging-Konzept zur trachealen Fistelsanierung bei sepsisassoziiertem ARDS. Anaesthesist 65:696–702CrossRef

64.

Westermaier T, Stetter C, Kunze E et al (2016) Controlled hypercapnia enhances cerebral blood flow and brain tissue oxygenation after aneurysmal subarachnoid hemmorrhage: results of a phase I study. Neurocrit Care 25:205–214CrossRefPubMed

65.

Westhoff M, Bachmann M, Braune S et al (2016) Schweres hyperkapnisches Atemversagen bei akuter COPD-Exazerbation: Stellenwert von Beatmung und ECCO₂R. Dtsch Med Wochenschr 141:1758–1717CrossRefPubMed

Titel: Extrakorporale Verfahren zur Lungenunterstützung
verfasst von: S. Braune
A. Sieweke
D. Jarczak
Prof. Dr. S. Kluge
Publikationsdatum: 29.05.2017
Verlag: Springer Medizin
Schlagwörter: ECMO
ECMO
Erschienen in: Medizinische Klinik - Intensivmedizin und Notfallmedizin / Ausgabe 5/2017
Print ISSN: 2193-6218
Elektronische ISSN: 2193-6226
DOI: https://doi.org/10.1007/s00063-017-0304-y

Neu im Fachgebiet AINS

23.04.2024 | Appendizitis | Nachrichten

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Extrakorporale Verfahren zur Lungenunterstützung

Zusammenfassung

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

S3-Leitlinie zu Pankreaskrebs aktualisiert

Update AINS

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2017

Nierenersatztherapie im akuten Nierenversagen

Plasmapherese zur Behandlung einer hypertriglyzeridämiebedingten Pankreatitis

Qualitätsindikatoren und strukturelle Voraussetzungen für Cardiac-Arrest-Zentren – Deutscher Rat für Wiederbelebung/German Resuscitation Council (GRC)

Extrakorporale Therapien bei Lebererkrankungen

Intrazerebrale Blutungen unter oraler Antikoagulation

Serum IgG levels and mortality in patients with severe sepsis and septic shock

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

S3-Leitlinie zu Pankreaskrebs aktualisiert

Update AINS